[go: up one dir, main page]

ATE218569T1 - Verbindungen zur hemmung der magensäuresekretion - Google Patents

Verbindungen zur hemmung der magensäuresekretion

Info

Publication number
ATE218569T1
ATE218569T1 AT98907306T AT98907306T ATE218569T1 AT E218569 T1 ATE218569 T1 AT E218569T1 AT 98907306 T AT98907306 T AT 98907306T AT 98907306 T AT98907306 T AT 98907306T AT E218569 T1 ATE218569 T1 AT E218569T1
Authority
AT
Austria
Prior art keywords
stomachic
inhibiting
compounds
acid secretion
secretion
Prior art date
Application number
AT98907306T
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE218569T1 publication Critical patent/ATE218569T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98907306T 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion ATE218569T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion

Publications (1)

Publication Number Publication Date
ATE218569T1 true ATE218569T1 (de) 2002-06-15

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907306T ATE218569T1 (de) 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion

Country Status (32)

Country Link
US (1) US6265415B1 (de)
EP (1) EP0971920B1 (de)
JP (1) JP2001512477A (de)
KR (1) KR20000075622A (de)
CN (1) CN1100056C (de)
AR (1) AR011134A1 (de)
AT (1) ATE218569T1 (de)
AU (1) AU723389B2 (de)
BR (1) BR9807457A (de)
CA (1) CA2280008A1 (de)
CZ (1) CZ291681B6 (de)
DE (1) DE69805787T2 (de)
DK (1) DK0971920T3 (de)
EE (1) EE04016B1 (de)
ES (1) ES2178169T3 (de)
HU (1) HUP0000720A3 (de)
ID (1) ID22218A (de)
IL (1) IL131122A0 (de)
IS (1) IS1901B (de)
MY (1) MY118822A (de)
NO (1) NO313009B1 (de)
NZ (1) NZ336878A (de)
PL (1) PL190379B1 (de)
PT (1) PT971920E (de)
RU (1) RU2193036C2 (de)
SE (1) SE9700661D0 (de)
SK (1) SK283903B6 (de)
TR (1) TR199902060T2 (de)
TW (1) TW568907B (de)
UA (1) UA64741C2 (de)
WO (1) WO1998037080A1 (de)
ZA (1) ZA981134B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
DE69737413T2 (de) * 1996-01-04 2007-10-31 Novartis Vaccines and Diagnostics, Inc., Emeryville Bakterioferritin aus helicobacter pylori
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
JP2005506322A (ja) * 2001-08-31 2005-03-03 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉワクチン接種
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
MXPA05003058A (es) 2002-09-19 2005-05-27 Schering Corp Nuevas imidazopiridinas como inhibidores de cinasa dependientes de ciclina.
JP4695588B2 (ja) * 2003-02-26 2011-06-08 スージェン， インク． プロテインキナーゼ阻害剤としてのアミノヘテロアリール化合物
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US20060194782A1 (en) * 2003-09-18 2006-08-31 Altana Pharma Ag Pharmacologically active imidazo[4,5-c] pyridines
AU2004285394B2 (en) 2003-11-03 2009-01-08 Astrazeneca Ab Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
JP4977465B2 (ja) 2004-07-28 2012-07-18 武田薬品工業株式会社 ピロロ［２，３−ｃ］ピリジン化合物、その製造方法および用途
CN101018789B (zh) 2004-09-03 2010-09-08 株式会社柳韩洋行 吡咯并[2,3-c]吡啶衍生物及其制备方法
RU2397170C2 (ru) * 2004-09-03 2010-08-20 Юхан Корпорейшн ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-b]ПИРИДИНА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
ES2367312T3 (es) 2004-09-03 2011-11-02 Yuhan Corporation DERIVADOS DE PIRROLO [3,2-c] PIRIDINA Y PROCESOS PARA LA PREPARACIÓN DE LOS MISMOS.
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
EP1861074B1 (de) * 2005-03-16 2013-04-24 Takeda GmbH Geschmacksmaskierte dosierform von roflumilast
PE20061110A1 (es) * 2005-03-24 2006-10-20 Glaxo Group Ltd Derivados de imidazopiridina como antagonistas de la bomba de acido (apa)
DK1959955T3 (da) 2005-12-05 2011-02-07 Pfizer Prod Inc Fremgangsmåde til behandling af abnorm cellevækst
WO2007066185A2 (en) 2005-12-05 2007-06-14 Pfizer Products Inc. Polymorphs of a c-met/hgfr inhibitor
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
RU2608611C2 (ru) * 2009-11-05 2017-01-23 Юниверсити Оф Нотр Дам Дю Лак СОЕДИНЕНИЯ ИМИДАЗО[1,2-а] ПИРИДИНА, ИХ СИНТЕЗ И СПОСОБЫ ПРИМЕНЕНИЯ
JP5975025B2 (ja) 2011-05-30 2016-08-23 アステラス製薬株式会社 イミダゾピリジン化合物
CN104822680B (zh) * 2012-11-30 2016-10-12 安斯泰来制药株式会社 咪唑并吡啶化合物
CN120117960A (zh) * 2025-05-12 2025-06-10 天津全和诚科技有限责任公司 一种杂质化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (de) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridinverbindungen und Verfahren zu ihrer Herstellung
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
MY118822A (en) 2005-01-31
UA64741C2 (uk) 2004-03-15
TR199902060T2 (xx) 2000-02-21
ZA981134B (en) 1998-08-25
RU2193036C2 (ru) 2002-11-20
SK109999A3 (en) 2000-01-18
KR20000075622A (ko) 2000-12-26
NO994078D0 (no) 1999-08-24
IS1901B (is) 2003-11-20
DE69805787T2 (de) 2003-01-02
HUP0000720A2 (hu) 2000-10-28
BR9807457A (pt) 2000-04-25
JP2001512477A (ja) 2001-08-21
AU723389B2 (en) 2000-08-24
SK283903B6 (sk) 2004-04-06
DE69805787D1 (de) 2002-07-11
TW568907B (en) 2004-01-01
DK0971920T3 (da) 2002-09-16
NO994078L (no) 1999-08-24
HK1024248A1 (en) 2000-10-05
CN1100056C (zh) 2003-01-29
NZ336878A (en) 2001-05-25
WO1998037080A1 (en) 1998-08-27
SE9700661D0 (sv) 1997-02-25
CA2280008A1 (en) 1998-08-27
MX9907650A (es) 2002-12-13
CZ291681B6 (cs) 2003-04-16
PT971920E (pt) 2002-11-29
CZ301499A3 (cs) 2000-02-16
EE04016B1 (et) 2003-04-15
PL190379B1 (pl) 2005-12-30
EP0971920A1 (de) 2000-01-19
PL335485A1 (en) 2000-04-25
EP0971920B1 (de) 2002-06-05
ES2178169T3 (es) 2002-12-16
IS5148A (is) 1999-08-05
AR011134A1 (es) 2000-08-02
CN1248257A (zh) 2000-03-22
EE9900367A (et) 2000-04-17
ID22218A (id) 1999-09-16
US6265415B1 (en) 2001-07-24
AU6314798A (en) 1998-09-09
NO313009B1 (no) 2002-07-29
HUP0000720A3 (en) 2001-01-29
IL131122A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
ATE218569T1 (de) Verbindungen zur hemmung der magensäuresekretion
DE69932397D1 (de) Zusammensetzung zur äusserlichen verwendung
ATE312101T1 (de) Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen
ATE233263T1 (de) Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
IL135574A0 (en) Substituted 4-amino-thiazol-2-yl compounds as cdk inhibitors
DE69831421D1 (de) Zusammensetzungen zur nasalen verabreichung
DE69733649D1 (de) Calcylitische verbindungen
ATE269861T1 (de) Substituierte indolalkansäure
DE69808631D1 (de) Neue spiroazabizyklische heterozyklische verbindungen
FI962800L (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
DE59701496D1 (de) Verfahren zur elektrochemischen Reduktion organischer Verbindungen
ATE311887T1 (de) Diphosphonsäure enthaltende zusammensetzungen
DE69807397D1 (de) Triazinylaminostilben Verbindungen
NO992853D0 (no) Sulfonsyre- eller sulfonylamino-N-(heteroaralkyl)-azaheterocyklylamidforbindelser
DE69709695T8 (de) Verfahren zur seitenzusammensetzung
ATE225364T1 (de) Bromotiacumicin verbindungen
DE69520055D1 (de) Verbindungen zur Hemmung der Thrombin
ZA200006419B (en) Use of APO B Secretion/MTP Inhibitors.
DE69715914D1 (de) Verfahren zur bleichung der zähne
DE59709665D1 (de) Verfahren zur Verzugskorrektur
ID20927A (id) Saluran ke bawah untuk senyawa pada menara proses kimia
DE59800237D1 (de) Verfahren zur Herstellung von wasserfreiem 2-Amino-1-methoxypropan
DE69702247D1 (de) Zusammensetzung zur inhibierung der polymerisierung
EE9700131A (et) Ühendid maohappesekretsiooni inhibeerimiseks
FI970329L (fi) Menetelmä suodattimen tukkeutumisen estämiseksi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee